Tim Cheetham

Insulin-like growth factors (IGFs) and IGF-I treatment in the adolescent with insulin-dependent diabetes mellitus.

D. Dunger, T. Cheetham, E. Crowne, 1995, Metabolism: clinical and experimental.

The Effects of Repeated Daily Recombinant Human Insulin‐like Growth Factor I Administration in Adolescents with Type 1 Diabetes

D. Dunger, J. Holly, T. Cheetham, 1995, Diabetic medicine : a journal of the British Diabetic Association.

The effect of cessation of growth hormone (GH) therapy on bone mineral accretion in GH-deficient adolescents at the completion of linear growth.

D. Dunger, P. Carroll, W. Drake, 2003, The Journal of clinical endocrinology and metabolism.

The role of IGF-binding proteins in mediating the effects of recombinant human IGF-I on insulin requirements in type 1 diabetes mellitus.

D. Dunger, C. Acerini, J. Samra, 2001, The Journal of clinical endocrinology and metabolism.

Recombinant human insulin-like growth factor-I abolishes changes in insulin requirements consequent upon growth hormone pulsatility in young adults with type I diabetes mellitus.

D. Dunger, J. Samra, J. Holly, 1998, Metabolism: clinical and experimental.

Does Recombinant Human Insulin-Like Growth Factor I Have a Role in the Treatment of Type I (Insulin Dependent) Diabetes During Puberty?

D. Dunger, D. Dunger, T. Cheetham, 1995, Journal of pediatric endocrinology & metabolism : JPEM.